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Inhibiting transmission of Plasmodium is an essential strategy in malaria eradication, and the biological 
process of gamete fusion during fertilization is a proven target for this approach. Lack of knowledge of 
the mechanisms underlying fertilization have been a hindrance in the development of transmission-
blocking interventions. Here we describe a protein disulphide isomerase essential for malarial 
transmission (PDI-Trans/PBANKA_0820300) to the mosquito. We show that PDI-Trans activity is male-
specific, surface-expressed, essential for fertilization/transmission, and exhibits disulphide isomerase 
activity which is up-regulated post-gamete activation. We demonstrate that PDI-Trans is a viable anti-
malarial drug and vaccine target blocking malarial transmission with the use of PDI inhibitor bacitracin 
(98.21%/92.48% reduction in intensity/prevalence), and anti-PDI-Trans antibodies (66.22%/33.16% 
reduction in intensity/prevalence). To our knowledge, these results provide the first evidence that PDI 
function is essential for malarial transmission, and emphasize the potential of anti-PDI agents to act as 
anti-malarials, facilitating the future development of novel transmission-blocking interventions.
Malaria remains a significant widespread health challenge with an estimated 216 million cases and 435,000 deaths 
globally in 20171. Recent approaches have significantly reduced global burden but recent progress has stalled1, 
and it is widely accepted that a range of new tools will be required to attain malaria elimination2. The causative 
agent of malaria, the protozoan parasite Plasmodium, is transmitted almost exclusively by anopheline mosqui-
toes. Transmission of Plasmodium from vertebrate to mosquito hosts is entirely dependent on the circulation of 
sexually viable gametocytes within circulating blood, which differentiate into micro- (male) and macro- (female) 
gametes upon ingestion by the mosquito within a blood meal. The essential process of fertilization is a two stage 
process, initiated by gamete adhesion, followed by membrane fusion3,4. A small number of proteins have pre-
viously been implicated in plasmodial fertilization; the 6-Cys protein family members P48/45, P47 and P230 
have demonstrable roles in the mutual recognition and adhesion of micro- and macro-gametes5–7, whereas the 
conserved male-specific Class II fusion protein HAP2/GCS1 has been shown to be the key driver of membrane 
fusion by mediating merger of lipid bilayers3,4. Following successful fertilization, resulting zygotes develop into 
ookinetes, which migrate to and invade the mosquito midgut, establishing infection in the insect. Despite the 
key importance of parasitic transmission and its undoubted potential as a point to disrupt the plasmodial lifecy-
cle with various therapeutic classes8, our knowledge of the mechanisms underlying fertilization and subsequent 
zygote formation in Plasmodium is surprisingly incomplete.
It is recognized that to achieve malarial control or eradication, it is vital to use interventions that inhibit 
transmission from humans to mosquitoes2. A potential mechanism to achieve this is to target Plasmodium 
using transmission-blocking interventions (TBIs); i.e. transmission blocking vaccines (TBVs), or transmission 
blocking drugs (TBDs) against parasitic sexual stages9–11. Antibodies targeting three of the five currently proven, 
potent TBV targets (P48/45, P230, HAP2) have demonstrable localization to proteins found on the plasma mem-
brane of the gametes12–22, indicating the potential value of targeting this lifecycle stage21. Additionally, multiple 
anti-malarial compounds have been demonstrated to have activity against this parasitic stage23–27. In summary, 
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the comparatively short life span, fragility, and availability of proteins on the surface of the Plasmodium male 
gamete make targeting this stage of the lifecycle a potential method of impeding transmission11,27. Similarly, 
potent TBIs targeting the parasitic ookinete post-fertilization are well characterized in multiple vaccine and drug 
studies10,17,18,28–30.
Protein Disulphide Isomerase (PDI) (EC: 5.3.4.1) is a multifunctional member of the thioredoxin superfam-
ily of redox proteins, characterized by the presence of the βαβαβαββα fold31. PDIs typically have three cat-
alytic activities; disulphide isomerase, thiol-disulphide oxidoreductase, and redox-dependent chaperone. PDI 
homologues have been identified in multiple species, where they are “classically” located in the endoplasmic 
reticulum (ER) and facilitate the folding and assembly of secretory and membrane proteins within the lumen32. 
In Plasmodium, a small number of proteins have been putatively identified (by sequence homology) as PDI-like 
molecules in Plasmodium falciparum, vivax, knowlesi, berghei and yoelii33–35. Conclusive demonstration of PDI 
activity has currently only been demonstrated with PF3D7_0827900/PDI-833, with transcription and transla-
tion demonstrated in asexual blood schizonts, gametocytes and sporozoites. Knowledge regarding the process of 
disulphide bond-dependent protein folding in Plasmodium is scarce.
Similarly, an increased understanding of transmission and mechanisms of fertilization within Plasmodium 
is vital, and offers prospective opportunities for the development of novel TBIs. Here, we describe the identi-
fication, characterization and role of a protein disulphide isomerase (PDI-Trans/PBANKA_0820300) essential 
for malarial transmission to the mosquito host in P. berghei. We demonstrate that PDI-Trans is transcribed and 
translated across the entire parasitic lifecycle, and exhibits activity at the sexual stages of the lifecycle, when fertili-
zation of gametes occurs. We show that PDI-Trans function is male specific after microgamete release, and essen-
tial for successful fertilization/transmission, and exhibits disulphide isomerase function which is up-regulated 
post-gamete activation. Furthermore, we show that PDI-Trans is a viable anti-malarial drug and vaccine target, 
expressed on the surface of the sexual stages of Plasmodium, by blocking malarial transmission with the use of 
repurposed compounds that target PDI activity, and anti-PDI-Trans peptide antibodies. These results demon-
strate that protein disulphide isomerase function is essential for malarial transmission; emphasize the potential 
of anti-PDI agents to act as anti-malarials, and demonstrate the potential utility of rationally-selected targets to 
facilitate the development of novel anti-malarial transmission-blocking interventions.
Results
PDI-Trans is located on the surface on the transmission stages of P. berghei. Previous proteomic 
analysis of a P. berghei male gamete proteome generated in36–38 followed by advanced bioinformatics analysis 
encompassing a suite of functional and localization-based algorithms36 identified the expression of PDI-Trans 
(PBANKA_0820300) in the male gamete, and suggested that the resulting transmembrane protein was poten-
tially located on the surface of the plasma membrane of male gametes. A brief analysis of PDI-Trans is described 
within39, where following a BarSeq Screen for asexual growth on an extensive library of non-clonal P. berghei KO 
parasites, posited that the gene is dispensable for the progression of blood-stage parasitemia. Our subsequent 
analysis of transcription levels by RT-PCR support this, demonstrating that PDI-Trans transcripts were present 
in wild-type asexual erythrocytic stages of the gametocyte the deficient strain 2.33, in addition to non-activated 
(Gc−) and activated (Gc+) gametocytes, ookinetes and sporozoites of the parental line 2.34 (Fig. 1A). To inves-
tigate the cellular localization of PDI-Trans across the parasitic lifecycle targeted-single homologous recombina-
tion was utilized to generate a transgenic P. berghei parasite expressing the endogenous PDI-Trans protein with a 
C-terminal EGFP fusion tag. Successful integration following drug selection was confirmed by PCR (Fig. 1B). The 
presence of the EGFP tag caused no observable impact on blood or sexual stages, and did not impact transmission 
through An. stephensi mosquitoes. Immunofluorescence microscopy on non-permeablized parasites confirmed 
PDI-Trans-GFP expression at the surface of activated male gametes and ookinetes (Fig. 1C). Live microscopy of 
mixed blood stages, female gametes and fixed immunofluorescence of sporozoites demonstrated that PDI-Trans-
GFP is expressed across the entire parasitic lifecycle (Figure S1).
PDI-Trans is essential for parasite transmission, is male specific and demonstrates classical PDI 
activity. To investigate the function of PDI-Trans targeted gene disruption was used to replace the entire 
PDI-Trans coding sequence. This was performed by double homologous recombination as described in39,40, 
with constructs designed and manufactured by PlasmoGem (Sanger Institute, UK). Following dilution clon-
ing of drug-resistant parasites, genotyping by PCR of two independently produced clones (Fig. 2A) indicates 
that the replacement construct had integrated at the targeted site, disrupting the endogenous locus. Consistent 
with previous predictions40,41, examination of mice infected with ΔPDI-Trans clones showed that the parasites 
underwent normal asexual development in erythrocytes (Figure S2). Rates of gametocytogenesis and sex ratio 
were unaffected, and gametocytes were able to emerge from their host cells and differentiate into gametes when 
exposed to standard gamete activation conditions (i.e. drop in pH or temperature, presence of xanthaurenic 
acid). To examine non-inactivated gametes, incubation in coelenterazine loading buffer followed by Nycodenz 
purification was performed42. To examine for a specific role during fertilization we specifically examined in vitro 
ookinete formation in blood collected from mice infected with ΔPDI-Trans parasites. Blood cultures from mice 
infected with ΔPDI-Trans parasites failed to produce ookinetes, a finding confirmed by triplicate experiments 
on two independent ΔPDI-Trans clones (Fig. 2B). To further explore this phenotype in vivo, An. stephensi mos-
quitoes were fed on mice infected with ΔPDI-Trans parasites in triplicate studies, and 12 days later microscopy 
was used to examine the presence of oocysts (Figure S3). Triplicate experiments of each clone showed a mean 
reduction of 94.38% inhibition in intensity and 63.68% inhibition in oocyst prevalence with in ΔPDI-Trans clone 
1, and a 96.43%/65.62% inhibition in intensity/prevalence with ΔPDI-Trans clone 2 when compared to wild type 
P. berghei (Table 1). The phenomenon of total blockade in transmission in vitro, while still observing low levels in 
vivo, is often observed with fertilization-null phenotypes following gene deletion (e.g. following KOs of HAP2 and 
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P48/453,6), and is often attributed to the fragile nature of the midgut epithelium post-blood meal. The resulting 
oocysts are morphologically normal and produce sporozoites that are capable of successfully establishing a blood 
stage infection. These results suggest that Trans-PDI plays a key role in the successful of Plasmodium.
Cross-fertilization studies, with pre-characterized sex-specific mutants, such as the male-deficient map2 or 
female-defective nek4 mutant43,44, make it possible to identify gender-specific sterility phenotypes in P. berghei. 
As demonstrated in Fig. 2C, neither Δmap2 nor Δnek4 strains produce ookinetes when cultured alone, but when 
cultures containing both KO lines were mixed, Δnek4 male gametes are able to fertilize map2 female gametes, 
restoring fertility and the capacity to produce ookinetes (Fig. 2C). Reduced conversion rates (compared with wild 
type parasites) are expected3,42,43, due to the persistence of Δnek4 female and Δmap2 gametes which are unable to 
fertilize. In ΔPDI-Trans /Δnek4 crosses the PDI-Trans female gametes were fertilized by Δnek4 micro-gametes, 
but Δmap2 females remained unable to differentiate into ookinetes in ΔPDI-Trans/Δmap2 crosses (Fig. 2C), 
indicating that ΔPDI-Trans males are sterile. Correspondingly, these results demonstrate that during plasmodial 
fertilization, PDI-Trans is essential for microgamete (male) fertility.
PDI enzymes typically catalyze the rearrangement of disulphide bonds between cysteine residues within 
proteins. To determine whether PDI-Trans exhibits classical PDI activity we utilized a fluorescent PDI 
insulin-reduction assay to determine reductase activity. Recombinant human PDI was used as a positive control 
for PDI activity, and the well-characterized PDI inhibitor bacitracin was used as a negative control. Gametocytes 
from ΔPDI-Trans, ΔPDI-Trans Comp (See below) and wild type lines were purified on a density gradient and 
used in the assay in either a non-activated or activated form. PDI activity was expressed as a percentage rel-
ative to the positive control (Fig. 2D). In wild type parasites, PDI activity is increased post-gametocyte acti-
vation, implicating broad PDI activity throughout gamete activation/fertilization. The activated gametes of the 
ΔPDI-Trans line had significantly reduced PDI activity with respect to wild type gametes, specifically indicating 
that PDI-Trans exhibits true PDI reductase function during fertilization. PDI activity was significantly increased 
when ΔPDI-Trans was complemented with the endogenous gene (ΔPDI-Trans Comp). To investigate whether 
complementation restored not only PDI activity, but the ability of these parasites to successfully fertilize we per-
formed ookinete conversion assays. Wild type parasites had a mean conversion rate of 77.98%. Ookinete conver-
sion was not observed in the ΔPDI-Trans parasite line. Conversely, ΔPDI-Trans Comp parasites exhibited a mean 
ookinete conversion rate of 72.25% indicating that complementation of the PDI-Trans restored the ability to of 
male gametes to fertilize. Assays were performed in triplicate (Fig. 2E).
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Figure 1. Constitutive expression of Plasmodium berghei PDI-Trans, and localization on the surface of 
gametocytes and ookinetes. (A) RT-PCR analysis of PDI-Trans in asexual blood stages using the non-
gametocyte producing strain 2.33; non-activated (Gc−) and activated (Gc+) gametocytes; purified in vitro 
ookinetes and day 21 salivary gland dissected sporozoites. The analysis was complemented with alpha-tubulin 
loading controls (B). PCR confirmation of integration of egfp into the PDI-Trans locus. Oligonucleotides 35 
and 14 were used to detect integration. Oligonucleotide 91 and 92 were used to detect DHFR presence, pbs25 
oligonucleotides were used as positive controls. P. berghei WT 2.34 gDNA was used as a negative control for 
integration. (C) IFA of fixed, non-permeablised PDI-Trans-GFP parasites probed with anti-GFP; exflagellating 
male gametocytes (top) and ookinetes (bottom). Each panel shows an overlay of GFP fluorescence (green) and 
DNA labelled with DAPI (blue). White scale bar = 5 μm.
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Figure 2. Deletion of PDI-Trans strongly inhibits transmission and is male specific. (A) Diagnostic PCR with 
genomic DNA templates and primers 69 and 70 to test for the presence of PDI-Trans, and primers 72 and 9 
to detect a unique 930 bp product across the integrations site. (B) The bar chart shows ookinete conversion 
rates for wild type and both ΔPDI-Trans clones. Conversion rate is expressed as a percentage of P28-positive 
parasites that had progressed to the ookinete stage (error bar indicates SEM; n = 3). Asterisks indicate P 
value < 0.05 Paired t test (C). In vitro ookinete conversion analysis demonstrates that PDI-Trans mutant shows 
production cross-fertilisation with the Δnek4 sterility mutant, which produces functional males only, and not 
with Δmap2 mutant, which produces functional females only. (error bar indicates SEM; n = 3). (D) PDI activity 
of purified whole parasite active and non-activated gametocytes from wild type, ΔPDI-Trans and ΔPDI-Trans 
Comp parasite lines. PDI activity is expressed as a percent relative to the positive control (human recombinant 
PDI). Bacitracin at 1 mM was used on human recombinant PDI as a control for a 50% reduction of activity as 
outlined by kit protocol. Experiments were performed in triplicate (error bar indicates SEM; n = 3). Asterisks 
indicate P value < 0.05 Paired t test. (E) Bar chart of ookinete conversion rates for wild type ΔPDI-Trans and 
ΔPDI-Trans Comp parasite lines. Conversion rate is expressed as a percentage of P28-positive parasites that had 
progressed to the ookinete stage (error bar indicates SEM; n = 3). Asterisks indicate P value < 0.05 Paired t test.
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Malarial fertilization is inhibited reversibly by the PDI inhibitor Bacitracin in vitro. To further 
explore PDI-Trans activity, and to examine the ability of specific PDI inhibitors to block malarial transmission, we 
utilized the classical PDI inhibitor bacitracin44. The peptide antibiotic bacitracin was first reported to be an inhib-
itor of PDI in 198145, and has subsequently been used in a wide range of studies to demonstrate the role of PDI in 
cellular processes, including glioma cell invasion46, melanoma cell death47, viral entry48,49, and platelet function50. 
Subsequent experimentation has demonstrated direct interaction of PDI with bacitracin, resulting in disulfide 
bond formation between an open thiol of the bacitracin thiazoline ring, and corresponding cysteines within the 
substrate‐binding domain of PDI51. Bacitracin has proven low membrane permeability51, giving it utility as a tool 
to assess PDI-dependent cell-surface reductase activity52. In vitro addition of bacitracin pre-fertilization resulted 
in a dose-dependent reduction of exflagellation centres (defined as motile flagellate male gametes bound to at 
least three additional cells), with a complete inhibition in formation of exflagellation centers at 3 mM (Fig. 3A). 
This subsequently inhibited the ability of gametocytes to form ookinetes, with complete inhibition of ookinete 
conversion at 3 mM bacitracin (Fig. 3B). In order to test whether bacitracin has a broad and non-specific toxic 
effect on parasites, potentially unrelated to PDI-Trans function, gametocytes were pre-incubated in bacitracin at a 
range of concentrations for 30 minutes, washed to remove the PDI inhibitor, then assayed for formation of exflag-
ellation centers/ookinetes respectively (post-wash). Results show that parasites pre-incubated with bacitracin, 
then washed, resulted in no detectable reduction (Paired t test) in the number of exflagellation centres compared 
to the untreated control across all concentrations examined (Fig. 3C,D).
In an attempt to further examine the activity of PDI-Trans and the mechanism of PDI-inhibitor based block-
ade of transmission, following bacitracin treatment we examined the number of visible free floating male gametes 
present, compared with the number of exflagellation centers present (rosettes comprising the adherence of newly 
emerged microgametes adhering to neighboring erythrocytes, defined as a motile male gamete adhered to three 
cells). As bacitracin concentrations increased. the number of visible exflagellation centres decreased, conversely, 
the number of free floating observed microgametes was unaffected (Fig. 3E), suggesting that PDI activity is essen-
tial for the association of male gametes to additional cells to form exflagellation centers, but not for the ability of 
gametogenesis/activation to form microgametes.
Malarial transmission is inhibited by Bacitracin in P. berghei and P. falciparum. To test the ability 
of bacitracin to block the transmission of P. berghei ex vivo we performed standard membrane feeding assays 
(SMFA) in triplicate with 0.3, 1 and 3 mM doses of bacitracin (Fig. 4A–C). Bacitracin inhibited transmission at 
all concentrations in a dose-dependent manner with a maximum inhibition in oocyst intensity of 98.21% and 
infection prevalence of 92.48% with 3 mM bacitracin (Table 2).
To investigate if PDI function is implicated in fertilization in additional Plasmodium species, and to extend 
our observations in P. berghei to human malaria parasites, we performed SMFAs with P. falciparum gametocyte 
cultures in the presence of bacitracin. Given the results observed with P. berghei we chose to perform the P. falci-
parum feeds at the highest concentration of bacitracin (3 mM) in triplicate to detect maximal effect (Fig. 4D–F). 
The addition of bacitracin significantly inhibited transmission, with a mean inhibition in oocyst intensity of 
95.05% and an inhibition of oocyst prevalence of 81.71% observed (Table 3).
PDI-Trans can be targeted specifically with antibodies to block transmission in vitro and ex 
vivo. Activity of the membrane impermeant53 drug Bacitracin and localization strongly suggest PDI-Trans 
is located on the surface of the microgamete and ookinete, therefore the ability of anti-PDI-Trans antibodies 
to initiate a specific anti-parasitic transmission blocking response was additionally examined. A polyclonal 
anti-peptide antibody was raised against residues bioinformatically predicted to be within the extracellular 
domain of PDI-Trans (amino acids 30–43). Antibodies were raised in rabbits, IgG purified, and examined for 
their ability to inhibit transmission in vitro and ex vivo. Anti-PDI-Trans IgG recognized both non-permeabilized 
gametocytes and ookinetes by IFA (Fig. 5A). Staining was absent in secondary only controls Fig. 5B), and on 
activated ΔPDI-Trans male gametes (Fig. 5C) indicating the ability of these antibodies to specifically recognize 
natively folded PDI-Trans on the gamete and ookinete surface.
To examine the ability of PDI-Trans to act a transmission blocking antigen, in vitro ookinete conversion 
assays were perfumed in the presence of anti-PDI-Trans. Anti-PDI-Trans inhibited ookinete conversion in a 
dose-dependent manner, further suggesting specificity. At antibody concentrations of 50, 100, 250 and 500 μg/
ml, ookinete formation was inhibited by 14.3%, 33.2%, 38.7% and 75.4% respectively. In contrast, as previously 
demonstrated4, the presence of the isotypic IgG UPC10 (negative control) had no discernable effect on ookinete 
conversion (Fig. 5D).
Wild 
type
ΔPDI-Trans 
Clone 1
Wild 
type
ΔPDI-Trans 
Clone 2
Mean intensity (n = 3) 59.81 3.19 60.17 2.23
Mean prevalence (n = 3) 92.67 34 93.86 32.67
Inhibition in intensity (%) — 94.38a — 96.43a
Inhibition in prevalence (%) — 63.68b — 65.62b
Table 1. Mean in vivo evaluation of deleting PDI-Trans on transmission by direct feeding. The mean 
(from three replicates) inhibition in intensity (mean number of oocysts per midgut) and prevalence of two 
independent PDI-Trans knockout clones were calculated with respect to wild type controls. aP < 0.05, Mann-
Whitney U test bP < 0.05, Fisher’s exact test.
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The transmission blocking activity of anti-PDI-Trans antibodies was additionally assessed by triplicate SMFA 
(Fig. 5E–G). Given the in vitro results observed previously (Fig. 5D), we assessed in vivo transmission blocking 
ability of anti-PDI-Trans antibodies only at the highest concentration where an in vitro effect was demonstrated. 
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Figure 3. The PDI inhibitor bacitracin reversibly inhibits Plasmodium berghei fertilization. (A) Exflagellation 
centers in the presence of Bacitracin at 0, 0.03, 0.3, 1 mM. Asterisks indicate P value < 0.05 Paired t test. (B) 
In vitro ookinete development assay supplemented with Bacitracin at 0, 0.03, 0.3, 1 and 3 mM. Results are 
shown as percent inhibition in ookinete conversion. Asterisks indicate P value < 0.05 Paired t test, ns indicate 
P value not significant. (C) Exflagellation centers after 30 minutes in the presence of Bacitracin at 0, 0.03, 
0.3, 1. P value < 0.05 Paired t test indicates P value not significant at any concentration. (D) In vitro ookinete 
development assay supplemented with Bacitracin at 0, 0.03, 0.3, 1 and 3 mM for 30 min prior to removal of 
Bacitracin. Results are shown as percent inhibition in ookinete conversion. P value < 0.05 Paired t test indicates 
P value not significant at any concentration. (E) Triplicate counts of free floating male gametes and male 
gametes in exflagellation centers. Represented as a percentage of total events observed in the presence of 0, 0.3, 1 
and 3 mM Bacitracin.
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Anti-PDI-Trans antibodies significantly inhibited P. berghei transmission in all experiments. At a concentration 
of 500 μg/ml anti-PDI-Trans antibodies inhibited oocyst intensity by a mean of 66.22% and reduced prevalence 
of infection by 33.16% (Table 4).
Discussion
Fertilization is a key process in the Plasmodium lifecycle, encompassing the active fusion of activated male 
(micro) and female (macro) gametes to form a zygote within the mosquito bloodmeal. Despite its essential nature 
to the success of the parasitic lifecycle, the cellular and molecular mechanisms that underlie fertilization remain 
largely opaque. Merely three proteins have been discovered that have a perceptible role in the mutual recognition 
of Plasmodium gametes; the 6-Cys family members, P48/45, P47 and P2305. The specific mechanism of action 
of these proteins are currently unknown. Following gamete recognition, the plasma membranes of the male and 
female gametes come into intimate contact and fuse, resulting in cytoplasmic continuity. The conserved class 
II fusion protein HAP2 is essential for gamete fusion during fertilization, and initiates merger of lipid bilayers 
post gamete adhesion. Following a (currently unidentified) trigger, it is postulated that a short-conserved region 
within the Plasmodium HAP2 ectodomain becomes exposed on the microgamete membrane surface, leading 
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Figure 4. The PDI inhibitor bacitracin inhibits transmission in Plasmodium berghei and Plasmodium 
falciparum. (A–C) Triplicate P. berghei standard membrane feeding assays with Bacitracin compared to 
control at concentrations of 0.3, 1 and 3 mM. Individual data points represent the number of oocysts found in 
individual mosquitoes 12-days post feed. Horizontal bars indicate mean intensity of infection, whilst error bars 
indicate S.E.M within individual samples. Asterisks indicate P value < 0.05 Mann-Whitney U test, ns indicate 
P value not significant. (D–F) Triplicate P. falciparum standard membrane feeding assays with Bacitracin 
compared to control at a concentration of 3 mM. Individual data points represent the number of oocysts found 
in individual mosquitoes 8-days post feed. Horizontal bars indicate mean intensity of infection, whilst error 
bars indicate S.E.M within individual samples. Asterisks indicate P value < 0.05 Mann-Whitney U test.
Control 0.3 mM 1 mM 3 mM
Mean intensity (n = 3) 13.17 10.68 2.32 0.23
Mean prevalence (n = 3) 77.37 72.32 38.29 5.81
Inhibition in intensity (%) — 17.20a 82.77a 98.21a
Inhibition in prevalence (%) — 6.72b 50.23b 92.48b
Table 2. Overall evaluation of transmission blocking effect of PDI inhibitor bacitracin in P. berghei by SMFA. 
Mean (from three replicates) reductions in intensity (mean number of oocysts per midgut) and prevalence with 
bacitracin at 0.3, 1 and 3 mM were calculated with respect to control feeds. aP < 0.05, Mann-Whitney U test 
bP < 0.05, Fisher’s exact test.
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to the subsequent parallel trimerization of protein subunits4,54,55. Polar residues within this “fusion loop” are 
subsequently inserted into the macrogamete membrane, followed by a conformational change in HAP2 domain 
III which distorts the target membrane, causing hemifusion followed by fusion/cytoplasmic continuity. Further 
related upstream and downstream effector molecules that specifically mediate the process of fertilization are at 
present unclear.
Here, we demonstrate that protein disulphide isomerase function, specifically encoded by a single plasmodial 
gene (PDI-Trans/PBANKA_0820300) is essential for malarial transmission. We demonstrate that PDI-Trans is 
constitutively expressed throughout the parasitic lifecycle, in both the blood and mosquito stages, but is only 
essential in the male gamete. This is consistent with transcriptomic data described in55, where transcripts of 
PBANKA_082030 have demonstrated upregulation in male gametes. Absence of PDI-Trans only confers a 
detectable effect post-gamete activation, prior to gamete adhesion, and is null for male fertility, and consequently, 
zygote/ookinete formation, and transmission to the mosquito host. Complementation of the disrupted locus 
restores fertility. Furthermore, we demonstrate reductase activity, indicative of classical PDI activity. Inhibition 
of PDI-Trans using the widely available (topical) antibiotic and PDI inhibitor, bacitracin, reversibly blocks plas-
modial transmission in vivo and ex vivo. Specifically, the process of gamete activation remains unaffected by 
bacitracin, whereas the ability of treated gametes to adhere to other cells (i.e. form exflagellation centers) appears 
to be compromised. Bacitracin-derived transmission blockade is observed in both P. berghei and P. falciparum. 
Finally, we show that antibodies specifically raised against the extracellular region of PDI-Trans can recognize the 
surface of the sexual stages of the parasite by immunofluorescence, and can initiate transmission-blocking activity 
both in vitro and ex vivo.
In all living cells, the appropriate formation and cleavage of disulphide bonds between cysteine residues in 
secreted and membrane anchored proteins is essential for native conformation, and therefore, function. PDIs 
are traditionally known to be versatile enzymes with key roles in the mediation of disulfide bond formation, 
isomeration and reduction in the endoplasmic reticulum33. PDI function is also associated with varied chaperone 
activity32. Little is known regarding the expression and function of PDI-like proteins in Plasmodium. A previous 
study34 has bioinformatically identified nine PDI-like molecules across five species of malaria parasites (four in 
falciparum, one in vivax, berghei, knowlesi and yoelii), indicated by the presence of classical thioredoxin domains. 
A more detailed analysis of one of these PDI candidates in P. falciparum; PfPDI-8 (PF3D7_0827900), demon-
strated expression within the endoplasmic reticulum of asexual blood schizonts, gametocytes and sporozoites, 
with biochemical analysis indicating a function in the disulfide-dependent conformational folding of a recom-
binant form of the erythrocyte-binding protein (and putative bloodstage vaccine target) EBA-175. As further 
evidence of the chaperone function of PDI enzymes, studies utilizing the overexpression of PfPDI-8 resulted in 
the enhanced expression and folding of the transmission-blocking vaccine candidate, Pfs25, in a Picha pasto-
ris expression system56. Broadly, PDI function is bioinformatically predicted to be conferred by multiple ORF 
throughout the parasitic genome, with recent bioinformatics predictions (PlasmoDB) suggesting the presence 
of six PDI-related ORFs in P. berghei (with homologues in P. falciparum). Expression, localization and function 
of these proteins are still largely undefined. Future study to further dissect the function of PDIs (and associated 
mechanisms of protein folding) in Plasmodium may be advantageous.
Although classically considered to be key mediators of protein folding in the endoplasmic reticulum, key 
evidence showing localization and function of PDIs in other cell compartments does exist. In some organisms, 
PDIs have been demonstrated to on occasion escape the ER, and exhibit cytoplasmic and cell surface localization, 
where their predominant function appears to be the reduction of disulphide bonds33,57. In terms of fertilization, 
PDI activity on the sperm head has previously proved to be essential for sperm-egg cell fusion in multiple ver-
tebrates32,58–60, and implicated in male fertility in mice61,62. PDI function has previously been implicated in the 
progression of multiple infectious diseases, with a specific role in mediating pathogen entry. In viruses, over-
expression of PDI enhances the fusion of vial membranes, leading to increased internalization of HIV-163. Cell 
surface PDI has been shown to facilitate the infection of HeLa cells by mouse polyoma virus64, and in endothelial 
cells a surface localized (lipid-raft associated) PDI reduces β1 and β2 integrins, allowing for the entry of dengue 
virus52,65. Its function is also essential for release of cholera toxin active chain A from the ER to the cytosol of the 
infected cell66. In protozoan pathogens, previous experimentation has demonstrated that increased levels of PDI 
enhance phagocytosis of the L. chagasi promastigote (but not the amastigote)67. It has previously been hypothe-
sized that T. gondii and L. donovani PDI could be putative targets for vaccine development68,69. The specific func-
tion of PDI-Trans in the parasite is still unknown, however, it is clear that successful fertilization in Plasmodium 
requires the presence and function of a range of proteins with conserved disulphide bonds between cysteine 
Control 
Feed 1
Bacitracin 
Feed 1
Control 
Feed 2
Bacitracin 
Feed 2
Control 
Feed 3
Bacitracin 
Feed 3
Mean intensity 15.83 0.96 18.15 0.52 12.81 0.76
Mean prevalence 91.30 16 78.57 10 81.25 20
Inhibition in intensity (%) — 93.93 — 97.14 — 94.07
Inhibition in prevalence (%) — 82.48 — 87.27 — 75.38
Table 3. Mean ex vivo evaluation of transmission blocking effect of PDI inhibitor bacitracin in P. falciparum. 
The mean (from three replicates) changes in intensity (mean number of oocysts per midgut) and prevalence 
with Bacitracin at 3 mM were calculated with respect to control feeds. aP < 0.05, Mann-Whitney U test 
bP < 0.05, Fisher’s exact test.
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residues on the gamete surface. The 6-Cys family members P48/45, P47, P230 are all definitively evidenced to 
mediate gamete adhesion, whereas HAP2 requires the correct formation of multiple crucial disulphide bridges 
to enable membrane fusion. It cannot be discounted that PDI-Trans may in some way catalyse disulphide bond 
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Figure 5. Anti-PDI-Trans antibodies inhibit fertilization and transmission in Plasmodium berghei. IFA of 
wildtype P. berghei ANKA male gametes and ookinetes with (A). anti PDI-Trans and (B). Secondary-only 
control antibodies (green) DAPI (blue). IFA of male gametes and ookinetes with anti PDI-Trans shows broad 
surface staining. White scale bars = 5 μm (C). IFA of ΔPDI-Trans gametes with anti PDI-Trans. Absence 
of staining illustrates anti PDI-Trans recognises native protein. White scale bar = 10 μm (D). Inhibition in 
ookinete conversion in in vitro ookinete development assay with anti PDI-Trans compared to negative control 
antibody UPC10 at concentrations of 0, 50, 100, 250 and 500 µg/ml. Asterisks indicate P value < 0.05 Paired 
t test, ns indicate P value not significant. (E–G) Triplicate standard membrane feeding assays with anti PDI-
Trans compared with negative control antibody UPC10 at a concentration of 500 µg/ml. Individual data points 
represent the number of oocysts found in individual mosquitoes 12-days post feed. Horizontal bars indicate 
mean intensity of infection, whilst error bars indicate S.E.M within individual samples. Asterisks indicate P 
value < 0.05 Mann-Whitney U test, ns indicate P value not significant.
α UPC10 500 
μg/ml
α PDI-Trans 500 
μg/ml
Mean intensity (n = 3) 31.37 9.82
Mean prevalence (n = 3) 93.28 62.18
Inhibition in intensity (%) — 66.22a
Inhibition in prevalence (%) — 33.16b
Table 4. Mean ex vivo evaluation of transmission blocking effect of anti-PDI-Trans antibodies. The mean (from 
three replicates) change in intensity (mean number of oocysts per midgut) and prevalence with anti PDI-Trans 
antibody at 500 µg/ml were calculated with respect to appropriate negative control antibody UPC10 at the same 
concentration. aP < 0.05, Mann-Whitney U test bP < 0.05, Fisher’s exact test.
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rearrangement in one of these transmission-essential proteins, exposing key residues critical for fertility-based 
function.
The results described here clearly indicate that PDI-Trans is a potential target for anti-malarial strategies 
to successfully inhibit malarial transmission. The generation of novel TBIs to reduce disease burden is a key 
component of the current anti-malarial strategy, and it is accepted that to achieve eradication, it will be hugely 
advantageous to use interventions that inhibit transmission of parasites from humans to mosquitoes2. We demon-
strate that bacitracin reversibly inhibits malarial transmission with high efficacy, and additionally, that antibodies 
targeting PDI-Trans mediate significant transmission reducing immunity. It should be noted that bacitracin is 
already an FDA approved compound, traditionally used clinically against gram-positive bacteria. This example 
illustrates the potential value of re-purposing drugs with observed efficacy against non-malarial species. Previous 
studies examining the anti-malarial efficacy of bacitracin only examined impact on asexual growth, where no 
effect was demonstrated70. The data here provides further evidence that anti-malarial transmission blocking effi-
cacy can be achieved by targeting the male/micro gamete. Previously described compounds effective against the 
process of fertilization (methylene blue and atovaquone) are effective in blocking transmission, as are antibod-
ies against multiple male gamete-surface proteins22–24. A deeper understanding of transmission and the mecha-
nisms of fertilization within Plasmodium will be advantageous to develop novel interventions in the future. More 
broadly, PDI-like proteins are expressed across multiple species and taxa, including in a range of pathogens of 
veterinary and clinical importance30,31,48. Given the ability of both anti-PDI-Trans compounds and antibodies to 
inhibit malarial transmission described here, and the proven role of PDI function in the regulation of infection 
across multiple species, it is logical to suggest that future studies may want to examine the possibility of targeting 
PDI proteins/functions using specifically designed novel anti-malarial drugs or vaccines.
Materials and Methods
General parasite maintenance. Parasite maintenance was carried out as described in71. P. berghei was 
maintained in ~6 week-old female TO mice (Harlan)ƒ. If necessary, hyper-reticulosis was induced three days 
pre-infection by treating intraperitoneally (i.p) with 200 μl phenylhydrazinium chloride (PH; 6 mg/ml; ProLabo). 
Infections were monitored via Giemsa-stained thin smears as described previously43.
Purification of gametocytes. Purification of gametocytes was achieved using a protocol modified from7. 
Mice were treated i.p with 200 μl phenylhydrazinium chloride (PH; 6 mg/ml in PBS; ProLabo UK). Day four 
post infection (p.i.) mice were treated with sulfadiazine (Sigma) at 20 mg/L in their drinking water for two days 
to eliminate asexual blood stage parasites. On day six p.i. mice were bled by cardiac puncture into heparin and 
gametocytes separated from uninfected erythrocytes on a 48% NycoDenz gradient (27.6% w/v NycoDenz in 
5 mM Tris-HCl, pH 7.20, 3 mM KCl, 0.3 mM EDTA) in coelenterazine loading buffer (CLB), containing PBS, 
20 mM HEPES, 20 mM Glucose, 4 mM sodium bicarbonate, 1 mM EGTA, 0.1% w/v bovine serum albumin, pH 
7.25. Gametocytes were harvested from the interface and washed twice in RPMI 1640 ready for activation of 
gamete formation.
Generation and analysis of transgenic parasite lines. PDI-Trans-GFP. To examine the expres-
sion and localization of PDI-Trans, the PDI-Trans-GFP transgenic line was created, introducing a C-terminal 
GFP tag to the native protein by single homologous recombination. The targeting construct pPDI-Trans-GFP 
was produced using the backbone of the EGFP-tagging vector p27772. The terminal 1527 bp of the PDI gene 
(PBANKA_082030) was synthesized to remove an internal ApaI site and introduce unique AvrII site within the 
gene and flanking KpnI and ApaI sites to the amplicon. This block was cloned in frame into ApaI/KpnI sites of 
p277, resulting in pPDI-Trans -GFP. For transfection, this construct was linearized at a unique AvrII site within 
the PDI sequence.
Parasites were transfected using the Nucleofector device (Amaxa Biosystems) as described pre-
viously65.  Integration of the DNA constructs into the chromosome was confirmed by PCR 
f lanking a region upstream from the 5 ′  integration site into the EGFP sequence (oligo 35; 
5′-GCATGTGCGATTGTATTGGG-3; oligo 14; 5′-ACGCTGAACTTGTGGCCG-3′) and the pres-
ence of the DHFR selection cassette (oligo 91 5 ′- TTCGCTAAACTGCATCGT -3 ′ ;  oligo 92 
5′-GTACTTAATGCCTTTCTCCT-3′). Oligos against the Pbs25 gene (PBANKA_0051500) were used 
as positive control (oligos F1: 5′-CAACTTAGCATAAATATAATAATGCGAAAGTTACCGTGG-3′; F2 
5′-CCATCTTTACAATCACATTTATAAATTCCATC-3′). GFP expression in transfected, drug resistant para-
sites were confirmed by fluorescence microscopy. Two independent clones were obtained from two independent 
transfections, demonstrating identical phenotypes and GFP expression.
ΔPDI-Trans. To examine the function of PBANKA_082030 the ΔPDI-Trans transgenic line was gener-
ated. The plasmid was designed and constructed by PlasmoGEM (PlasmoGem ID PbGEM-239637) using 
recombinase-mediated engineering followed by a Gateway® mediated exchange41,73. Prior to transfection the 
construct was digested by NotI to release the P. berghei insert from its vector backbone. Parasites were transfected 
using the Nucleofector device (Amaxa Biosystems) as described previously72,73. Integration of the DNA constructs 
into the chromosome was confirmed by PCR region flanking 5′ of the modified target locus and 3′ DHFR selec-
tion cassette (oligo 72; 5′- ACGTGCATGTGCGATTGTATTGGGT -3; oligo 9; 5′- CTTTGGTGACAGATACTAC 
-3′) and the absence of the wildtype locus (oligo 69 5′- ATGGGAAACTATACTTATATATATATTTTTTTCA -3′; 
oligo 70 5′- TTATAAATCAGAATTTTCTTCTCCTTC -3′). Two independent clones were obtained from two 
independent transfections, demonstrating statistically indistinguishable phenotypes.
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ΔPDI-Trans-Comp. For the complementation construct the clonal knockout line was injected into mice and 
mice were treated with 5-Fluorocytosine (5FC) nucleoside analog (Sigma) drinking water, 1.5 mg/ml to recycle 
the Hdhfr-yfcu marker. The subsequent marker free line was subjected to dilution cloning to achieve a pure popu-
lation of marker free parasites. Following this the full length endogenous PBANKA_082030 gene was transfected 
on top using the artificial chromosome library clone mapping to PBANKA_082030 from PlasmoGEM (clone ID 
PbAC02-74d11) as described previously (Figure S4)39,73.
RT-PCR. P. berghei RNA was isolated from gametocyte deficient strain 2.33, activated or inactivated gameto-
cytes, ookinetes and sporozoites from wild type P. berghei 2.34 strain using Trizol reagent (Invitrogen). cDNA 
synthesis was performed using Prime script kit from (Clonetech). PCR reactions were set up to amplify sec-
tions of PDI-Trans ORF (Forward 5′-ATGGGAAACTATACTTATATATATATTTTTTTCA-3′; and reverse 5′- 
CTACATATTTATCGACATCTCCAA-3′). The expected RT amplicon was 481 bp. The ubiquitously expressed 
α-tubulin gene PBANKA_0522700 was amplified for each sample to ensure amplifiability of cDNA from respective 
RNA samples (Forward, 5′-CCAGATGGTCAAATGCCC-3′; Reverse, 5′-CTGTGGTGATGGCCATGAAC-3′). 
The expected products were 435 bp (cDNA). Thirty RT–PCR cycles were carried out with denaturation for 1 min 
at 94 °C, annealing for 45 secs at 50 °C, and extension for 1.5 min at 68 °C, and products were visualized on a 0.8% 
agarose gel.
Direct feeding assay (DFA). Routine maintenance of P. berghei was carried out as described above. Prior 
to challenge, mice were PH treated, and 3 days later infected i.p. with 106 P. berghei ANKA 2.34 or ΔPDI-Trans 
parasites. Three-days post-infection, animals were anesthetized, and >50 female Anopheles stephensi mosquitoes 
allowed to blood feed on each mouse. Twenty-four hours later, unfed mosquitoes were removed. Mosquitoes were 
maintained on 8% (w/v) fructose, 0.05% (w/v) p-aminobenzoic acid at 19–22 °C and 50–80% relative humidity. 
Day 14 post-feeding, mosquito midguts were dissected and oocyst intensity and prevalence observed by standard 
phase microscopy and recorded. Reduction in oocyst intensity and prevalence in knockout mice were calculated 
with respect to wild type controls.
In Vitro ookinete conversion assay (IVOA). PH-treated mice were injected with 5 × 107 parasites i.p. On 
day 3 or 4 of infection, parasitaemia was counted on a Giemsa- stained tail blood smear and exflagellation of male 
gametocytes was checked by addition of a drop of exflagellation medium to a drop of tail blood. Hosts observed 
to have exflagellating parasites were exsanguinated by cardiac puncture and each 20 μl of blood taken up in 450 μl 
ookinete medium. Individual cultures were then added to pre-prepared 24 well plates (Nunc) and incubated for 
24 h at 19 °C. Cultures were harvested after 24 h by centrifugation (500 × g, 5 min), washed once in 100 μl ookinete 
medium, and the pellet taken up in 50 μl ookinete medium containing Cy3-conjugated Pbs28 mAb clone 13.1 
(1:500). Ookinetes and macrogametocytes were then immediately counted by fluorescence microscopy. Ookinete 
conversion rates were calculated as described previously18. In bacitracin experiments harvested parasites were 
added to ookinete medium containing a range of Bacitracin (Sigma Aldrich: #B0125) concentrations and either 
left in or washed and put into fresh medium 30 min after drug treatment. In antibody experiments harvested par-
asites were added to ookinete medium containing anti-PDI-Trans rabbit sera or anti-UPC10 (negative control). 
In each set of experiments results were collated from three separate experiments and inhibition expressed as the 
percentage reduction in ookinete conversion with respect to wild type parasites, samples with no bacitracin or 
the anti-UPC10 control.
Crosses. At day 3 post infection of phenylhydrazine treated mice, infected with parasites with either 
ΔPDI-Trans, Δnek4, Δmap2 and wt were harvested by heart puncture and mixed at a 1:1 ratio in ookinete 
medium. After 24 h, ookinete conversion assays were performed by incubating samples with 13.1 antibody (anti-
body against Pb28 conjugated with Cy3). The proportion of ookinetes to all 13.1-positive cells (unfertilised mac-
rogametes and ookinetes) was established, counting fields at 60 × magnification. Experiments were performed in 
biological triplicate42,43.
PDI activity assay. PDI activity was measured in a microplate PDI inhibitor screening assay kit from Abcam 
(ab139480). Briefly, ΔPDI-Trans ΔPDI-Trans Comp and wild-type gametocytes were purified42. Non-activated 
gametocytes were Nycodenz purified in coelentrazine loading buffer and liberated from the red blood cell with 
lysis buffer before use. Both activated and non-activated gametocytes of each parasite line were used in the assay 
and the PDI-catalyzed reduction of insulin in the presence of Dithiothreitol resulting in the formation of insulin 
aggregates which bind avidly to the red-emitting fluorgenic PDI detection reagent were measured on Tecan, 
Infinite M200 Pro. The background media signal for each sample was subtracted and PDI activity was calculated 
as a percent relative to the positive control (human recombinant PDI). Bacitracin at 1 mM was used on human 
recombinant PDI as a control for a 50% reduction of activity as outlined by kit protocol. Experiments were per-
formed in triplicate.
Standard membrane feeding assay (SMFA). P. berghei. Female An. stephensi (SDA 500 strain) were 
starved for twenty-four hours and then fed on heparinized P. berghei infected blood using standard membrane 
feeding methods [6460]. For each feed, 350 µl of P. berghei ANKA 2.34 infected blood containing asexual and 
sexual stages of the parasite was mixed with 150 µl of PBS containing either antibody to yield final concentration 
of 500 μg/ml or drug at 0.3, 1 and 3 mM. Mosquitoes were handled, maintained and analyzed as described above. 
Reductions in oocyst intensity and prevalence was calculated with respect to control feeds as described in4.
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P. falciparum. Mature gametocytes of P. falciparum (NF54) were produced in vitro as described previously74 
with slight modifications. Briefly, mature gametocyte cultures (0.5 to 2% final gametocytaemia) were fed for 
15–20 min at room temperature to An. gambiae mosquitoes through an artificial membrane kept at 37 °C. For 
each feed 300 µl of mature P. falciparum gametocytes were mixed with bacitracin at a concentration of 3 mM. 
Engorged mosquitoes were housed in pots at 26 °C and 60–80% relative humidity. On days 7–9, midguts were 
dissected and the results analyzed as outlined in the above P. berghei section.
Antibody production. Synthetic peptide to PDI-Trans (VSDDFAKKVNHLTHC) was produced, conjugated 
to KLH and used to raise polyclonal rabbit antisera (Genscript, USA). Resulting sera was IgG purified and vali-
dated by Genscript via ELISA.
Microscopy. Immunofluorescence assay (IFA). PDI-Trans-GFP parasites were assessed by IFA for the pres-
ence of GFP tag with anti-GFP, Roche at a dilution of 1:500. Signal was detected by Alexa Fluor 488-labelled goat, 
anti-mouse IgG (Molecular Probes) at 1:500. Rabbit antibodies to PDI-Trans were assessed by IFA on wild-type 
P. berghei ANKA 2.34 gametocytes and ookinetes at a dilution of 1:500. Signal was detected by Alexa Fluor 
488-labelled goat, anti-rabbit IgG (Molecular Probes) at 1:500. Parasites were cultured and IFAs were performed 
as described previously4. Slides were visualized under x60 objective magnification using a fluorescence micro-
scope (EVOSFL Cell Imaging System, Life Technologies).
Live imaging. PDI-Trans-GFP parasites were examined for GFP signal by live microscopy. Parasites were cul-
tured and allowed to settle on glass slides before microscopy. Slides were visualized under X40 objective magnifi-
cation using a fluorescence microscope (Leica DMR).
Statistical analysis. Statistical analysis was performed using Graphpad Prism. For DFA, SMFA and DMFA, 
significance was assessed using Mann–Whitney U (to examine differences in intensity) and Fisher’s exact prob-
ability tests (to examine differences in prevalence). Parametric ELISA tests were assessed using t-test. P val-
ues < 0.05 were considered statistically significant (***< 0.0001, ***0.001, **0.001–0.01, *0.01–0.05).
Ethical statement. All procedures were performed in accordance with the UK Animals (Scientific 
Procedures) Act (PPL 70/8788) and approved by the Imperial College AWERB. The Office of Laboratory Animal 
Welfare Assurance for Imperial College covers all Public Health Service supported activities involving live verte-
brates in the US (no. A5634-01).
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All datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
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